Thorac Cardiovasc Surg 2008; 56(5): 262-268
DOI: 10.1055/s-2008-1038420
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Early and Late Results of Restrictive Mitral Valve Annuloplasty in 121 Patients with Cardiomyopathy and Chronic Mitral Regurgitation

S. Geidel1 , M. Lass1 , K. Krause2 , C. Schneider2 , S. Boczor2 , K.-H. Kuck2 , J. Ostermeyer1
  • 1Abteilung für Herzchirurgie, Asklepios Klinik St. Georg, Hamburg, Germany
  • 2Abteilung für Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany
Further Information

Publication History

received October 5, 2007

Publication Date:
09 July 2008 (online)

Abstract

Objective: This study investigated the early and late results of restrictive mitral valve (MV) annuloplasty in patients with chronic mitral regurgitation (MR) and advanced ischemic (ICM) or dilated cardiomyopathy (DCM). Methods: From October 2001 to September 2006, 121 patients (age: 69 ± 9 years) with a left ventricular ejection fraction (LVEF) of 30 ± 9 % and chronic MR grade 3 – 4 (ICM: n = 102, DCM: n = 19) underwent restrictive prosthetic ring annuloplasty (downsizing of 2.7 ± 0.8 ring sizes). Eighty-five ICM-patients had indications for concomitant coronary artery bypass grafting (CABG). All patients were restudied at 7 ± 1 days, 3 ± 1 and 30 ± 12 months after surgery to assess survival, residual MR, New York Heart Association (NYHA) class and left ventricular (LV) function (end-systolic/end-diastolic dimensions/volume indexes and LVEF). Data were analyzed exploratively. Results: 30-day mortality was 3.3 %; survival at follow-up was 95 % and 91 %, respectively. Postoperative recurrence of significant MR (> grade 2) was absent in all patients. NYHA class, LV dimensions/volume indexes and LVEF improved significantly after surgery in both groups (p < 0.0005). A prediction of continuous postoperative improvement of myocardial function in the sense of reverse remodeling could be demonstrated by univariate logistic regression for ischemic etiology and concomitant CABG (p = 0.0001). In DCM-patients or ICM-patients without CABG, the postoperative benefit on myocardial function was limited. Conclusion: Restrictive mitral valve (MV) annuloplasty corrected chronic MR in cardiomyopathy patients with low mortality and improved contractility. Surgery also prevented recurrence of significant MR, although the phenomenon of postoperative continuous reverse myocardial remodeling could not be verified in cases with a non-ischemic etiology or ICM without concomitant CABG.

References

  • 1 Bolling S F, Deeb G M, Brunsting L A, Bach D S. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy.  J Thorac Cardiovasc Surg. 1995;  109 676-682
  • 2 Bax J J, Braun J, Somer S T, Klautz R, Holman E R, Versteegh M IM, Boersma E, Schalij M J, van der Wall E E, Dion R A. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling.  Circulation. 2004;  110 (Suppl II) II‐103-II‐108
  • 3 Geidel S, Lass M, Schneider C, Groth G, Boczor S, Kuck K H, Ostermeyer J. Downsizing of the mitral valve and coronary revascularization in severe ischemic mitral regurgitation results in reverse left ventricular and left atrial remodeling.  Eur J Cardiothorac Surg. 2005;  27 1011-1016
  • 4 Carpentier A. Cardiac valve surgery – the “French correction”.  J Thorac Cardiovasc Surg. 1983;  86 323-337
  • 5 Bitran D, Merin O, Klutstein M W, OD-Allah S, Shapira N, Silberman S. Mitral valve repair in severe ischemic cardiomyopathy.  J Card Surg. 2001;  16 79-82
  • 6 Dreyfus G, Milaiheanu S. Mitral valve repair in cardiomyopathy.  J Heart Lung Transplant. 2000;  19 S73-S76
  • 7 Suma H, Isomura T, Horii T, Sato T, Kikuchi N, Iwahashi K, Hosokawa J. Nontransplant cardiac surgery for end-stage cardiomyopathy.  J Thorac Cardiovasc Surg. 2000;  119 1233-1244
  • 8 Trichon B H, Felker G M, Shaw L K, Cabell C H, O'Connor C M. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.  Am J Cardiol. 2003;  91 538-543
  • 9 Hung J, Papakostas L, Tahta S A, Hardy B G, Bollen B A, Duran C M, Levine R A. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target.  Circulation. 2004;  110 (Suppl II) II‐85-II‐90
  • 10 McGee E C, Gillinov A M, Blackstone E H, Rajeswaran J, Cohen G, Najam F, Shiota T, Sabik J F, Lytle B W, McCarthy P M, Cosgrove D M. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation.  J Thorac Cardiovasc Surg. 2004;  128 916-924
  • 11 Grigioni F, Enriquez-Sarano M, Zehr K J, Bailey K R, Tajik A J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.  Circulation. 2001;  103 1759-1764
  • 12 Aklog L, Filsoufi F, Flores K Q, Chen R H, Cohn L H, Nathan N S, Byrne J G, Adams D H. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation?.  Circulation. 2001;  104 (Suppl I) I68-I75
  • 13 Trichon B H, Glower D D, Shaw L K, Cabell C H, Anstrom K J, Felker G M, O'Connor C M. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation.  Circulation. 2003;  108 (Suppl I) II103-II110
  • 14 Reece T B, Tribble C G, Ellman P I, Maxey T S, Woodford R L, Dimeling G M, Wellson H A, Crosby I K, Kern J A, Kron I L. Mitral repair is superior to replacement when associated with coronary artery disease.  Ann Surg. 2004;  239 671-677
  • 15 Grossi E A, Goldberg J D, LaPietra A, Ye X, Zakow P, Sussman M, Delianides J, Culliford A T, Esposito R A, Ribakove G H, Galloway A C, Colvin S B. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications.  J Thorac Cardiovasc Surg. 2001;  122 1107-1124
  • 16 Menicanti L, Di Donato M, Frigiola A, Buckberg G, Santambrogio C, Ranucci M, Santo D. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration.  J Thorac Cardiovasc Surg. 2002;  123 1041-1050
  • 17 Isomura T, Suma H, Yamaguchi A, Kobashi T, Yuda A. Left ventricular restoration for ischemic cardiomyopathy – comparison of presence and absence of mitral valve procedure.  Eur J Cardiothorac Surg. 2003;  23 614-619
  • 18 De Bonis M, Lapenna E, Verzini A, La Canna G, Grimaldi A, Torracca L, Maisano F, Alfieri O. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.  Interact Cardiovasc Thoracic Surg. 2006;  5 (Suppl 2) S219
  • 19 Di Giammarco G, Pano M, Gagliardi M, Giancane M, Pelini P, Di Mauro M. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it?.  Interact Cardiovasc Thoracic Surg. 2006;  5 (Suppl 2) S219
  • 20 Timek T A, Glasson J R, Lai D T, Liang D, Daughters G T, Ingels Jr N B, Miller D C. Annular height-to-commissural width ratio of annuloplasty rings in vivo.  Circulation. 2005;  112 I423-428
  • 21 Spoor M T, Geltz A, Bolling S F. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.  Circulation. 2006;  114 67-71
  • 22 Berdat P A, Seck T, Schoenhoff F, Eckstein F S, Stalder M, Englberger L, Carrel T P. New generation annuloplasty ring systems for correction of ischemic mitral regurgitation in CAD and dilated CMP: early results.  Thorac Cardiovasc Surg. 2007;  55 (Suppl 1) S38
  • 23 Acker M A, Bolling S, Shemin R, Kirklin J, Oh J K, Mann D L, Jessup M, Sabbah H N, Starling R C, Kubo S H Acorn Trial Principal Investigators and Study Coordinators for the. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial.  J Thorac Cardiovasc Surg. 2006;  132 568-577

Dr. Stephan Geidel

Abteilung für Herzchirurgie
Asklepios Klinik St. Georg

Lohmühlenstraße 5

2099 Hamburg

Germany

Email: Stgeidel@aol.com